These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10550465)

  • 1. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
    Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
    Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
    J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
    Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
    J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
    Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y
    J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
    Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links.
    Srivastava AK; Libanati C; Oberrauch W; Leenings J; Greenwald M; Baylink DJ
    J Bone Miner Metab; 2003; 21(3):134-44. PubMed ID: 12720047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis.
    Bettica P; Taylor AK; Talbot J; Moro L; Talamini R; Baylink DJ
    J Clin Endocrinol Metab; 1996 Feb; 81(2):542-6. PubMed ID: 8636265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
    Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
    Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases.
    Kraenzlin ME; Kraenzlin CA; Meier C; Giunta C; Steinmann B
    Clin Chem; 2008 Sep; 54(9):1546-53. PubMed ID: 18653826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
    de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
    Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
    Kawana K; Takahashi M; Hoshino H; Kushida K
    Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated and manual assays for urinary crosslinks of collagen: which assay to use?
    Seibel MJ; Woitge HW; Farahmand I; Oberwittler H; Ziegler R
    Exp Clin Endocrinol Diabetes; 1998; 106(2):143-8. PubMed ID: 9628247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.
    Pecherstorfer M; Seibel MJ; Woitge HW; Horn E; Schuster J; Neuda J; Sagaster P; Köhn H; Bayer P; Thiébaud D; Ludwig H
    Blood; 1997 Nov; 90(9):3743-50. PubMed ID: 9345061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
    Garnero P; Gineyts E; Arbault P; Christiansen C; Delmas PD
    J Bone Miner Res; 1995 Apr; 10(4):641-9. PubMed ID: 7610936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.